Brad Hively insider trades

Open-market stock purchases and sales by Brad Hively, Director at Starling Oncology, Inc, from SEC Form 4 filings since Jan 12, 2021.

Recent trades

DateStockTradeValue
Aug 21, 2026STLN Starling Oncology, IncSold$1.9M
Jul 27, 2026TOI Oncology Institute, IncBought (not open market)—
Dec 15, 2025TOI Oncology Institute, IncSold$50.3K
Nov 20, 2025TOI Oncology Institute, IncBought (not open market)—
Nov 20, 2025TOI Oncology Institute, IncBought (not open market)—

Companies traded

  • STLN Starling Oncology, Inc: 1 sale, last Aug 21, 2026
  • TOI Oncology Institute, Inc: 6 buys, 7 sales, last Jul 27, 2026

Get free alerts when Brad Hively files a new trade →